English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51242798    在线人数 :  692
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"ann lii cheng"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 501-510 / 690 (共69页)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-08-31T06:29:21Z Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients Yang S.-H.; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏 2021-08-31T06:29:21Z Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population Lin C.-H.; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; Huang C.-S.; ANN-LII CHENG; Lu Y.-S.; Asian Breast Cancer Cooperative Group
臺大學術典藏 2021-08-31T06:29:21Z Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma Shao Y.-Y.; Liu T.-H.; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:29:21Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:20Z Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma Alsina A.; Kudo M.; Vogel A.; ANN-LII CHENG; Tak W.Y.; Ryoo B.-Y.; Evans T.R.J.; L?pez L?pez C.; Daniele B.; Misir S.; Ren M.; Izumi N.; Qin S.; Finn R.S.
臺大學術典藏 2021-08-31T06:29:20Z Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations Chen C.-H.; Lu Y.-S.; ANN-LII CHENG; Huang C.-S.; Kuo W.-H.; Wang M.-Y.; Chao M.; Chen I.-C.; Kuo C.-W.; Lu T.-P.; Lin C.-H.
臺大學術典藏 2021-08-31T06:29:20Z Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-08-31T06:29:19Z Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma Shen Y.-C.; Hsu C.-L.; Jeng Y.-M.; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:19Z Milestones in the pathogenesis and management of primary liver cancer Nault J.-C.; ANN-LII CHENG; Sangro B.; Llovet J.M.
臺大學術典藏 2021-08-31T06:29:19Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors Lee J.-H.; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; ANN-LII CHENG; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C.

显示项目 501-510 / 690 (共69页)
<< < 46 47 48 49 50 51 52 53 54 55 > >>
每页显示[10|25|50]项目